Emanuele Zucca

Active 1990–2025

161
Papers
37,635
Citations
95
h-index
157
i10-index

Citations

Citations per year for Emanuele Zucca1991: 6 citations1992: 3 citations1993: 2 citations1994: 1 citations1995: 7 citations1996: 13 citations1997: 26 citations1998: 23 citations1999: 16 citations2000: 35 citations2001: 49 citations2002: 37 citations2003: 58 citations2004: 47 citations2005: 107 citations2006: 142 citations2007: 109 citations2008: 143 citations2009: 148 citations2010: 168 citations2011: 170 citations2012: 168 citations2013: 196 citations2014: 190 citations2015: 208 citations2016: 256 citations2017: 286 citations2018: 251 citations2019: 973 citations2020: 997 citations2021: 981 citations2022: 835 citations2023: 677 citations2024: 1,073 citations2025: 479 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,698 citing papers, 22.1% of this breakdownItaly: 927 citing papers, 7.6% of this breakdownGermany: 837 citing papers, 6.9% of this breakdownFrance: 818 citing papers, 6.7% of this breakdownUnited Kingdom: 807 citing papers, 6.6% of this breakdownChina: 757 citing papers, 6.2% of this breakdownSwitzerland: 547 citing papers, 4.5% of this breakdownSpain: 523 citing papers, 4.3% of this breakdownCanada: 450 citing papers, 3.7% of this breakdownNetherlands: 381 citing papers, 3.1% of this breakdownAustralia: 360 citing papers, 2.9% of this breakdownJapan: 297 citing papers, 2.4% of this breakdown
0%22.1%Other 23%

Fields

  • Medicine82.3%
  • Biochemistry, Genetics and Molecular Biology14%
  • Immunology and Microbiology2.2%
  • Computer Science0.4%
  • Mathematics0.3%
  • Engineering0.2%
  • Other0.6%

Topics

  • Lymphoma Diagnosis and Treatment21.5%
  • CNS Lymphoma Diagnosis and Treatment7.5%
  • Chronic Lymphocytic Leukemia Research5.9%
  • CAR-T cell therapy research5.5%
  • Viral-associated cancers and disorders5.1%
  • Cutaneous lymphoproliferative disorders research2.9%
  • Other51.6%

Coauthors

All papers

Open in search
  1. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    Authors: , , , , , , - Journal of Clinical Oncology 2014 cited by 5,552

  2. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 cited by 1,506

  3. Revised Response Criteria for Malignant Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2007 cited by 4,448

  4. Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2014 cited by 1,648

  5. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 906

  6. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Franco Cavalli, Emanuele Zucca, Luigi Maria Larocca, Gianluca Gaïdano, Stefan Hohaus, Carmelo Carlo‐Stella, Davide Rossi - Blood 2018 cited by 338

  7. Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 149

  8. Genomic profiling for clinical decision making in lymphoid neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfgang Hiddemann, Won Seog Kim, Rebecca L. King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, José I. Martín‐Subero, Miguel Á. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla‐Martínez, Scott J. Rodig, Andreas Rosenwald, Gilles Salles, Jesús F. San Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott - Blood 2022 cited by 161

  9. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandro Levis, Hans‐Joachim Schmoll, Franco Cavalli, Jürgen Finke, Michele Reni, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2016 cited by 599

  10. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2016 cited by 428

  11. Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Lorenz Thurner, Giuseppina Cabras, Elsa Pennese, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Antonella Ferranti, Kelly Cozens, Elvira Burger, Nicoletta Ielmini, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, IELSG32 study investigators - Leukemia 2022 cited by 162

  12. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Michael Pfreundschuh, Giuseppina Cabras, F. Angrilli, Maurilio Ponzoni, Martina Deckert, Letterio S. Politi, Jürgen Finke, Michele Reni, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus - The Lancet Haematology 2017 cited by 381

  13. Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2003 cited by 840

  14. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , , , , - Annals of Oncology 2020 cited by 341

  15. Marginal zone lymphomas

    Authors: , , - Hematological Oncology 2022 cited by 153

  16. Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

    Authors: , , , , , , , , , , , , , , , , , , - Blood Advances 2020 cited by 73

  17. The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

    Authors: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 283

  18. An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Hutchings, Sze Ting Lee, Josée M. Zijlstra, Ronald Boellaard - Scientific Reports 2023 cited by 34

  19. Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

    Authors: , , , , , , , , , - Cancer Discovery 2016 cited by 381

  20. Epidemiology of hematological malignancies

    Authors: , , - Annals of Oncology 2007 cited by 297

  21. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valter Gattei, Govind Bhagat, German Ott, Emanuele Zucca, Gianluca Gaïdano, Francesco Bertoni - Blood 2013 cited by 249

  22. MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Urban Novak, Renato Zambello, Emanuele Zucca, Kate Cwynarski - The Lancet Haematology 2021 cited by 104

  23. Genetic and phenotypic attributes of splenic marginal zone lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaïdano, Juan F. Garcı́a, B. Gerber, Paolo Ghia, María Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Inghirami, Marco Ladetto, Armando López‐Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Véronique Meignin, Michele Merli, Alden A. Moccia, Manuela Mollejo, Carlos Montalbán, Urban Novak, David Oscier, Francesco Passamonti, Francesco Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Salles, Elisa Santambrogio, Lydia Scarfò, Anastasios Stathis, Georg Stüssi, Julia T. Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thiéblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elı́as Campo, Laurence de Leval, Stefan Dirnhofer, Stefano Pileri, Miguel Á. Piris, Alexandra Traverse‐Glehen, Alexandar Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi - Blood 2021 cited by 97

  24. Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2018 cited by 116